Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
08/2003
08/21/2003US20030158197 Certain alkylene diamine-substituted heterocycles
08/21/2003US20030158185 Novel use of phenylheteroakylamine derivatives
08/21/2003US20030158105 Determining polypeptide sequence of at least one Bcr-Abl polypeptide expressed by the human cancer cell and comparing the polypeptide sequence of the Bcr-Abl polypeptide expressed by the human cancer cell to the Bcr-Abl polypeptide sequence
08/21/2003CA2476024A1 Pyrimidines as novel openers of potassium ion channels
08/20/2003EP1335907A1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
08/20/2003EP1335906A1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands
08/20/2003EP1335900A2 Alkylthio- and aryl(heteroyl)thio-substituted p-phenylenediamines, their manufacture and their use in rubber
08/20/2003EP1335899A2 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases
08/20/2003EP1194415B1 Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for their preparation
08/20/2003EP1150944B1 N2-phenylamidine derivatives
08/20/2003EP0883598B1 Use of aminophenol derivatives in oxidative hair dyes
08/20/2003EP0831829B1 Heterocyclic ring-fused pyrimidine derivatives
08/20/2003CN1437647A Supertwisted nematic liquid crystal displays, liquid crystal compositions and compounds
08/20/2003CN1437594A Substituted bicyclic derivatives for the treatment of abnormal cell growth
08/20/2003CN1437585A Method and compositions utilizing quinazolinones
08/20/2003CN1437484A New formulation comprising a beta-blocker and optionally a cholesterol-lowering agent
08/20/2003CN1118464C Novel pyrimidine derivatives and process producing the same
08/20/2003CN1118460C Pyrimidine derivatives as 5HT2C-receptor antagonists
08/20/2003CN1118459C Pyrimidinedione, pyrimidi netrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-adrenergic receptor antagonists
08/20/2003CN1118458C Pyrimidinyl derivatives as interleukin inhibitors
08/20/2003CN1118454C Heterocyclic derivative and medicine
08/20/2003CN1118449C Liquid crystal compound, liquid crystal containing liquid crystal compound and liquid crystal display device using the same composition
08/19/2003US6608204 Peptide aldehyde having arginine or arginine mimics at P1 and pyridone, pyrimidone, or uracil groups; antithrombosis agents
08/19/2003US6608199 Synthesis of chlorinated pyrimidines
08/19/2003US6608198 Hydrated forms of lopinavir; HIV protease inhibitor
08/19/2003US6608197 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
08/19/2003US6608061 Bisaryl compound and medicament for cancer treatment comprising the same
08/19/2003CA2099867C 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
08/19/2003CA2037528C 2-amino(fluoroalkoxy)pyrimidines and the preparation thereof
08/19/2003CA2026226C 6-substituted acyclopyrimidine nucleoside derivatives and antiviral agent containing the same as active ingredient thereof
08/14/2003WO2003066603A1 Quinazolinone derivatives and their use as cb agonists
08/14/2003WO2003066602A1 Process for producing 4-aminoquinazoline compound
08/14/2003WO2003066601A1 Pyrimidine compounds
08/14/2003WO2003066577A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
08/14/2003WO2003066574A1 Aromatic amino acid derivatives and medicinal compositions
08/14/2003WO2003066060A2 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
08/14/2003WO2003066059A1 Treatment of neuroblastoma
08/14/2003WO2003065789A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
08/14/2003WO2003053941A3 Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases
08/14/2003WO2003024955A3 Small molecule inhibitors of caspases
08/14/2003US20030153755 Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinases
08/14/2003US20030153597 Therapeutic treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease, nervous system disorders and cardiovascular disorders
08/14/2003US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same
08/14/2003US20030153586 7-oxo-pyridopyrimidines (I)
08/14/2003US20030153584 Such as cyclo-D-phenylglycyl-L-(2-(amino-3-mercaptobutanoic acid))
08/14/2003US20030153544 Fatty acid derivatives
08/14/2003US20030153516 Methods and materials for treating and preventing inflammation of mucosal tissue
08/14/2003US20030153463 Substituted aryl sulphonyl(thio)ureas
08/14/2003CA2476281A1 Pyrimidine compounds
08/14/2003CA2473778A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
08/13/2003EP1334968A1 Process for producing substituted aniline compound
08/13/2003EP1334083A2 1,4-disubstituted benzenes as insecticides
08/13/2003EP1333833A2 Novel compounds
08/13/2003EP1242427B1 Novel piperidine and piperazine derivatives as p2x7 receptor antagonists
08/13/2003EP1178987B1 Substituted benzoylisoxazoles and the use thereof as herbicides
08/13/2003EP0868501B1 Process for controlling cone tilt angle in mixtures of smectic liquid crystal compounds
08/13/2003CN1117748C Herbicidal 2,6-disubstd. pyridines and 2,4-disubstd. pyrimidines
08/13/2003CN1117731C Benzo-pentaheterocyclic ring sulfonyl urea compound, its preparation method and herbicide using said compound as active component
08/12/2003US6605747 Reacting the starting material, an alpha , alpha -difluorocyclohexylidene derivative with a halogen to produce an intermediate, reacting the intermediate with a phenol compound in presence of a base
08/12/2003US6605604 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
08/12/2003US6605299 Releasable linkage and compositions containing same
08/07/2003WO2003064399A1 Process for producing quinazolin-4-one derivative
08/07/2003WO2003064377A1 4,5-substituted-2-formylaminobenzamides and processes for their production and conversion
08/07/2003WO2003063874A1 Condensed heterocyclic compounds
08/07/2003WO2003063872A1 Non-sedating barbituric acid derivatives
08/07/2003WO2003063871A1 Phenylpyrimidine amines as ige inhibitors
08/07/2003WO2003063797A2 Cycloalkyl inhibitors of potassium channel function
08/07/2003WO2003063794A2 2,4-pyrimidinediamine compounds and their uses
08/07/2003WO2003063576A2 Arylsulfonamidobenzylic compounds
08/07/2003WO2002002593A3 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
08/07/2003US20030149266 Administering to a patient (a warm blooded animal, such as man) an effective amount of a pyrimidine derivative for treating cancer, cell proliferation, and inhibition of focal adhesion kinase effect
08/07/2003US20030149087 For therapy of atherosclerosis, gallstone disease, lipid disorders, obesity or a cardiovascular disorder
08/07/2003US20030149083 For therapy of inflammatory diseases, rheumatoid arthritis, inflammatory bowel diseases, systemic erythematodes, multiple sclerosis, Sjogren's syndrome, asthma, psoriasis, allergy, diabetes, cardiovascular diseases, arterial sclerosis
08/07/2003US20030149064 Pyrimidine compounds
08/07/2003US20030149062 Therapy of inflammatory diseases of the airways or intestines which by administering substances selected from quinazoline derivatives, 4-((3-chloro-4-fluorophenyl)amino)-6-((4-dimethylamino-cyclohexyl)amino) -pyrimido(5,4-d)pyrimidine
08/07/2003US20030149045 Therapy of graft versus host disease in a mammal by administering methotrexate and a quinazoline derivative
08/07/2003US20030149037 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc.
08/07/2003US20030148888 Novel triazolo pyrimidine compounds
08/07/2003US20030147845 O2-arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
08/07/2003CA2474451A1 Cycloalkyl inhibitors of potassium channel function
08/07/2003CA2474434A1 Condensed heterocyclic compounds
08/07/2003CA2474433A1 Arylsulfonamidobenzylic compounds
08/07/2003CA2474277A1 2,4-pyrimidinediamine compounds and their uses
08/06/2003EP1333029A1 Pyrimidine derivatives and herbicides containing the same
08/06/2003EP1332146A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332136A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1189929B1 Factor viia inhibitors
08/06/2003EP1187838B1 Thiazolopyrimidines useful as TNF-Alpha inhibitors
08/06/2003EP0934321B1 Thienopyrimidine with phosphodiesterase v inhibiting effect
08/06/2003EP0799209B1 Sulfonamides
08/06/2003CN1434827A 新的哌啶和哌嗪衍生物 The new piperidine and piperazine derivatives
08/06/2003CN1434821A Quinazoline derivatives for the treatment of tumours
08/06/2003CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists
08/06/2003CN1434715A Pharmaceutical compositions
08/06/2003CN1117084C Halogen pyrimidinyl aryl (thio) ethers as pesticides
08/06/2003CN1117080C Method for producing (hetero) aromatic hydroxylamines
08/06/2003CN1117071C Pesticides
08/05/2003US6603044 Phthalamide derivatives, or salt thereof agrohorticultural insecticide, and method for using the same
08/05/2003US6603014 Use of cyclic enamines as light protection agents
08/05/2003US6603011 3-pyridinyl compounds
1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 427